Day One Biopharmaceuticals, Inc.
NASDAQ:DAWN
12.15 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -188.917 | -142.181 | -72.754 | -43.843 | -16.984 |
| Depreciation & Amortization
| 0.383 | 0.531 | 0.199 | 0.155 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 39.341 | 27.242 | 13.321 | 0.526 | 0.111 |
| Change In Working Capital
| 9.418 | 6.564 | 2.695 | -0.357 | 0.444 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 2.316 | -1.484 | 1.542 | 0.132 | 0.014 |
| Other Working Capital
| 7.102 | 8.048 | 1.153 | -0.489 | 0.43 |
| Other Non Cash Items
| -7.078 | -2.03 | 8 | 30.03 | 11.914 |
| Operating Cash Flow
| -146.853 | -109.874 | -48.539 | -13.489 | -4.515 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.224 | -0.026 | -8 | -0.092 | 0 |
| Acquisitions Net
| 0 | 0.255 | 0 | 0 | 0 |
| Purchases Of Investments
| -443.838 | -394.206 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 575.44 | 139.158 | 0 | 0 | 0 |
| Other Investing Activites
| -3 | -0.255 | -8 | 0 | 0 |
| Investing Cash Flow
| 128.378 | -255.074 | -8 | -0.092 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 1 |
| Common Stock Issued
| 161.409 | 161.61 | 167.045 | 29.977 | 29.905 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 5.176 | 4.291 | 130.075 | 29.977 | 29.905 |
| Financing Cash Flow
| 163.997 | 165.901 | 297.12 | 29.977 | 30.905 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 145.522 | -199.047 | 240.581 | 16.396 | 26.39 |
| Cash At End Of Period
| 230.784 | 85.262 | 284.309 | 43.728 | 27.332 |